Constructive Genomics is a spin out from the laboratory of Prof. Jason Chin at the MRC Laboratory of Molecular Biology in Cambridge.
Our platform allow us to fundamentally reprogram the genetic code, and make molecules that nature could not make before. We will use our technologies to biosynthesize new classes of enzymes, pharmaceuticals and biomaterials.
If you would like to join our team, get in touch!
Location: United Kingdom, England, Little Chesterford
Employees: 1-10
Total raised: $15M
Investors 3
Date | Name | Website |
16.08.2022 | Amadeus Ca... | amadeuscap... |
06.11.2023 | OMX Ventur... | omx.vc |
18.08.2022 | Ahren Inno... | ahreninnov... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
15.08.2022 | Seed | $15M | Ahren Inno... | tech.eu/20... |
Mentions in press and media 4
Date | Title | Description | Source |
01.09.2022 | LifeArc helps create new MRC spin-out company | Our technology transfer team played a crucial role in the formation of Constructive Bio, a new Medic... | lifearc.or... |
15.08.2022 | Constructive bio launches with $15m seed investment to re-en... | Cambridge, UK - Constructive Bio announces its launch as a new UK-based biotechnology company follow... | cambridgen... |
15.08.2022 | Constructive Bio Raises USD15M in Seed Funding | Constructive Bio, a Cambridge, UK-based biotechnology company, raised $15m in seed funding. The rou... | finsmes.co... |
15.08.2022 | Re-engineering biology, Constructive Bio scores $15 million ... | Cambridge-based biotech startup Constructive Bio has raised $15 million in funding to create technol... | tech.eu/20... |